Last Updated: September 24, 2026

Details for New Drug Application (NDA): 020468

✉ Email this page to a colleague

NDA 020468 describes NASACORT ALLERGY 24 HOUR, which is a drug marketed by Chattem Sanofi and is included in one NDA. It is available from two suppliers. Additional details are available on the NASACORT ALLERGY 24 HOUR profile page.

The generic ingredient in NASACORT ALLERGY 24 HOUR is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for 020468

Tradename:	NASACORT ALLERGY 24 HOUR
Applicant:	Chattem Sanofi
Ingredient:	triamcinolone acetonide
Patents:	0

Pharmacology for NDA: 020468

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 020468

Anti-Inflammatory Agents
Glucocorticoids
Immunosuppressive Agents

Suppliers and Packaging for NDA: 020468

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468	NDA	Chattem, Inc.	41167-5800	41167-5800-1	1 BOTTLE, SPRAY in 1 CARTON (41167-5800-1) / 30 SPRAY, METERED in 1 BOTTLE, SPRAY
NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468	NDA	Chattem, Inc.	41167-5800	41167-5800-2	2 BOTTLE, SPRAY in 1 CARTON (41167-5800-2) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY

Profile for product number 002

Active Rx/OTC/Discontinued:	OTC	Dosage:	SPRAY, METERED;NASAL			Strength	0.055MG/SPRAY
Approval Date:	Oct 11, 2013	TE:		RLD:	Yes

Expired US Patents for NDA 020468

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	5,976,573	⤷ Start Trial
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	7,977,045	⤷ Start Trial
Chattem Sanofi	NASACORT ALLERGY 24 HOUR	triamcinolone acetonide	SPRAY, METERED;NASAL	020468-002	Oct 11, 2013	6,143,329	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.